Companies: 10,795·Total market cap: $144.5T
NeoGenomics, Inc.

NeoGenomics, Inc.

NEONASDAQHealthcare● Active
$10.95
+$0.05(+0.46%)
Market Cap$285163798
P/E Ratio—
52W High$13.74
52W Low$4.72
Overview

NeoGenomics, Inc. (NEO) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · NEO · as of Feb 17, 2026

Latest filing snapshot

2,500
+300+13.64%vs prior year

NeoGenomics, Inc. (NEO) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
2,500
Change (1Y)
+300
Growth % (1Y)
+13.64%
Revenue / Employee
$290.9K
Net Income / Employee
$-43.2K
Market Cap
$285M

NEO Employee Count

2008 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-02-172,500+300+13.64%
2025-02-182,200+100+4.76%
2024-02-202,100+0+0.00%
2023-02-242,100+100+5.00%
2022-02-252,000+300+17.65%
2021-02-251,700+0+0.00%
2020-02-281,700+200+13.33%
2019-02-261,500+500+50.00%
2018-03-131,000+62+6.61%
2017-03-14938+88+10.35%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Medical - Diagnostics & Research
#SymbolCompanyEmployees
#1
NeoGenomics, Inc.
NEO
NeoGenomics, Inc.YOU
2,500#2
Quanterix Corporation
QTRX
Quanterix Corporation
471#3
MDxHealth S.A.
MDXH
MDxHealth S.A.
312#4
Humacyte, Inc.
HUMA
Humacyte, Inc.
218#5
Arcturus Therapeutics Holdings Inc.
ARCT
Arcturus Therapeutics Holdings Inc.
174#6
Aclaris Therapeutics, Inc.
ACRS
Aclaris Therapeutics, Inc.
61#7
Sagimet Biosciences Inc.
SGMT
Sagimet Biosciences Inc.
14
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · NEO peer comparison

About NEO employees

NEO Employees · Headcount

NeoGenomics, Inc. (NEO) employee data is sourced from the annual SEC 10-K filing. As of 2025, NeoGenomics, Inc. had 2,500 full-time employees globally. Full-time employees only. Global consolidated headcount.

NeoGenomics, Inc. employs 2,500 full-time employees as of the latest filing within the Medical - Diagnostics & Research industry. Revenue per employee stands at $290,933, reflecting the company's operational efficiency.

NeoGenomics, Inc.'s workforce increased by 300 (13.64%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

NeoGenomics, Inc.'s revenue per employee of $290,933 positions it among the notable performers in the Medical - Diagnostics & Research sector for operational efficiency.

RevenueFinancial statementsNet incomeSEC filingsPrice historyForecast & ratingsOwnershipEarnings

Frequently Asked Questions

NEO Employees · 5 questions

As of the latest SEC 10-K filing (2025), NeoGenomics, Inc. had 2,500 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

NeoGenomics, Inc. employee counthow many employees does NeoGenomics, Inc. haveNEO total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-17